Omnitech Engineering shares to list today. Here’s what GMP indicates ahead of debut


Omnitech Engineering is headed for its stock market debut today, but grey market signals point to a muted start. The GMP for the Rs 583 crore IPO has slipped into negative territory ahead of listing, indicating expectations of a discount listing on BSE and NSE.

The book-built issue, which closed on February 27, comprised a fresh issue of 1.84 crore shares aggregating to Rs 418 crore and an offer for sale of 0.73 crore shares worth Rs 165 crore. The price band was set at Rs 216-227 per share, with the issue priced at the upper end at Rs 227.

At the issue price, the company commands a pre-IPO market cap of about Rs 2,807 crore. Post listing, promoter holding will dilute from about 94% to 74%.

The IPO received an overall subscription of 1.20 times. The QIB portion (excluding anchor) was subscribed 3 times, while the NII category saw 0.77 times subscription and the retail portion lagged at 0.35 times. The employee segment was subscribed 4.47 times. Ahead of the issue, the company raised Rs 174.60 crore from anchor investors.

Business profile and financials

Omnitech Engineering is engaged in manufacturing precision-engineered components, turnkey industrial automation solutions and customised mechanical systems. It caters to sectors such as automotive, aerospace, pharmaceuticals, food processing and general manufacturing.

The company operates three manufacturing facilities in Gujarat and had 1,807 permanent employees as of September 30, 2025. It reported an order book of over Rs 1,764 crore as of September 30, 2026.

For the six months ended September 30, 2025, total income stood at Rs 236.69 crore with profit after tax of Rs 27.78 crore. In FY25, revenue was Rs 349.71 crore and PAT was Rs 43.87 crore.

The company plans to utilise Rs 50 crore from the fresh issue towards repayment or prepayment of borrowings. It will also invest Rs 132.84 crore and Rs 100.71 crore towards setting up new projects at two proposed facilities, Rs 18.70 crore for capital expenditure at an existing facility and the balance for general corporate purposes.

While institutional demand was relatively strong, weak retail participation and the negative GMP suggest listing gains may be limited. Market participants will watch closely whether institutional interest provides support post listing or whether broader market volatility keeps the debut under pressure.



Source link

Leave a Reply

Back To Top